94 related articles for article (PubMed ID: 3120591)
1. Treatment of experimental intravitreal fibrin with tissue plasminogen activator.
Lambrou FH; Snyder RW; Williams GA; Lewandowski M
Am J Ophthalmol; 1987 Dec; 104(6):619-23. PubMed ID: 3120591
[TBL] [Abstract][Full Text] [Related]
2. Resolution of experimental intravitreal fibrin by tissue plasminogen activator.
Min WK; Kim YB
Korean J Ophthalmol; 1990 Dec; 4(2):58-65. PubMed ID: 2128708
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal clearance of tissue plasminogen activator in the rabbit.
Jaffe GJ; Green GD; McKay BS; Hartz A; Williams GA
Arch Ophthalmol; 1988 Jul; 106(7):969-72. PubMed ID: 3134000
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
Min WK; Kim YB; Lee KM
Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
[TBL] [Abstract][Full Text] [Related]
5. Collagen shield delivery of tissue plasminogen activator: functional and pharmacokinetic studies of anterior segment delivery.
Murray TG; Jaffe GJ; McKay BS; Han DP; Burke JM; Abrams GW
Refract Corneal Surg; 1992; 8(1):44-8; discussion 48-53. PubMed ID: 1554639
[TBL] [Abstract][Full Text] [Related]
6. A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.
Kamei M; Misono K; Lewis H
Am J Ophthalmol; 1999 Dec; 128(6):739-46. PubMed ID: 10612511
[TBL] [Abstract][Full Text] [Related]
7. Treatment of postvitrectomy fibrin pupillary block with tissue plasminogen activator.
Jaffe GJ; Lewis H; Han DP; Williams GA; Abrams GW
Am J Ophthalmol; 1989 Aug; 108(2):170-5. PubMed ID: 2502924
[TBL] [Abstract][Full Text] [Related]
8. Use of tissue plasminogen activator for intraocular fibrinolysis in dogs.
Gerding PA; Essex-Sorlie D; Vasaune S; Yack R
Am J Vet Res; 1992 Jun; 53(6):894-6. PubMed ID: 1626779
[TBL] [Abstract][Full Text] [Related]
9. Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Experimental treatment in a rabbit model.
Snyder RW; Lambrou FH; Williams GA
Arch Ophthalmol; 1987 Sep; 105(9):1277-80. PubMed ID: 3115240
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
[TBL] [Abstract][Full Text] [Related]
11. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy.
Hesse L; Nebeling B; Schroeder B; Heller G; Kroll P
Exp Eye Res; 2000 Jan; 70(1):31-9. PubMed ID: 10644418
[TBL] [Abstract][Full Text] [Related]
12. The effect of tissue plasminogen activator on retinal bleeding.
Sternberg P; Aguilar HE; Drews C; Aaberg TM
Arch Ophthalmol; 1990 May; 108(5):720-2. PubMed ID: 2110447
[TBL] [Abstract][Full Text] [Related]
13. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes.
Irvine WD; Johnson MW; Hernandez E; Olsen KR
Arch Ophthalmol; 1991 May; 109(5):718-22. PubMed ID: 1902663
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage.
Johnson RN; Olsen KR; Hernandez E
Arch Ophthalmol; 1989 Jun; 107(6):891-4. PubMed ID: 2499298
[TBL] [Abstract][Full Text] [Related]
15. Intraocular properties of urokinase-derived antiangiogenic A6 peptide in rabbits.
Koh HJ; Cheng L; Bessho K; Jones TR; Davidson MC; Freeman WR
J Ocul Pharmacol Ther; 2004 Oct; 20(5):439-49. PubMed ID: 15650519
[TBL] [Abstract][Full Text] [Related]
16. Use of tissue plasminogen activator in experimental hyphema.
Lambrou FH; Snyder RW; Williams GA
Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
[TBL] [Abstract][Full Text] [Related]
17. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit.
Johnson MW; Olsen KR; Hernandez E; Irvine WD; Johnson RN
Arch Ophthalmol; 1990 Feb; 108(2):259-63. PubMed ID: 2105712
[TBL] [Abstract][Full Text] [Related]
18. Detecting endotoxin contamination of ophthalmic viscosurgical devices: intracameral versus intravitreal assays in rabbits.
Buchen SY; Calogero D; Hilmantel G; Eydelman MB
Ophthalmology; 2012 Jul; 119(7):e11-8. PubMed ID: 22578451
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator treatment of postoperative intraocular fibrin.
Johnson RN; Olsen K; Hernandez E
Ophthalmology; 1988 May; 95(5):592-6. PubMed ID: 3140157
[TBL] [Abstract][Full Text] [Related]
20. The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.
Men G; Peyman GA; Genaidy M; Kuo PC; Ghahramani F; Blake DA; Bezerra Y; Naaman G; Figueiredo E
Retina; 2004 Apr; 24(2):199-209. PubMed ID: 15097878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
